Videos

If you get a glioblastoma, you usually only have about 15 months to live.This malignant tumour spreads rapidly through the brain and unfortunately cannot be cured. Yanti De Visser is working on a personalised treatment to already slow down the brain tumour - with success. "The first results show that our approach has the potential to extend patients' lives by years, rather than months," she says.

Every 3 minutes, a woman dies of ovarian cancer somewhere in the world. "Ovarian cancer is very sneaky. Most of the patients respond positively to the therapies initially provided to them, but eventually, the cancer comes back and is much more aggressive. As a result one in two ovarian cancer patients die within 5 years after diagnosis." But what if we were able to treat ovarian cancer with a new therapy using our cells?

Thanks to advanced proton therapy, doctors can precisely start irradiating brain tumours. Unfortunately, they do not yet dare to use this technique on tumours in the belly. Why? Because it's a bit like playing darts with a blindfold, while you have to hit a moving target, as Sophie Heymans explains in this video. She tells you about the technique she is working on to help doctors face this challenge.

Anyone who has ever looked for Waldo knows how hard he is to find. In her research on lung cancer, Rebekka Van Hoof (Uhasselt - KU Leuven - VITO) faces a similar task: she is searching within more than 100,000 so-called extracellular vesicles for 2 types -say 'Waldos'- that can help detect the disease early. But she is determined to narrow her search field. How? Watch her explain it in this video. 

Do you remember Pac-Man, from that old skool computer game? Well, did you know that there are Pac-Mans in every single cell of our body? They're called enzymes. Some of these enzymes work too fast or too slow, and this can cause severe diseases. Michaela Prothiwa (KU Leuven) explains how she wants to track down these malfunctioning enzymes using a clever piece of chemistry.

What if you only had 15 months to live? Hard to imagine, right? Yet every day, around 1,000 people worldwide hear this news. The verdict: glioblastoma, a malignant brain tumor. Yet a small group of patients manages to survive for more than 10 years with such a brain tumor. Brecht Decraene wants to finds out why.

"Each person is unique. So why do we still treat every woman with ovarian cancer the same way?" Liselore Loverix (KU Leuven - FWO) examines patient by patient and looks for errors in the DNA of their tumour cells. In this way, before treatment starts, she identifies which patient would benefit from a new, targeted therapy based on cancer drugs.

Thanks to new radiotherapy techniques, more and more patients with head and neck cancer are surviving. But for 70% of them, this radiation causes chronic swallowing problems, making it difficult to eat and drink. Hanne Massonet hopes to help them enjoy food and drink again by training their tongue, mouth, and throat muscles.

Have you ever tried to get the last cookie from the bottom of the jar but couldn't quite reach it? Now, what if that cookie can potentially help cure cancer? Wiktoria Wojtaczka (KU Leuven) is investigating terbium, a chemical element that can be turned into a drug for cancer. But the problem she faces in her research is pretty similar to that of the cookie stuck in the jar

Did you know that colon cancer is the third most deadly cancer worldwide? Unfortunately, while immunotherapy is quite effective in the treatment of many cancers, such as skin cancer, it only works in 5% of colon cancer patients. Sara Verbandt (KU Leuven) explains how she wants to make immunotherapy stand up against colon cancer.

Immunotherapy is a very promising therapy for cancer, but only 15 to 30% of the patients respond to this kind of therapy. Giving immunotherapy to patients without knowing whether they will respond is expensive and can even harm them. That's why Madhavi Andhari is looking for markers to tell apart responders from non-responders.

Imagine having to visit the toilet 30 times a day for 'number two'. That's not possible, right? Unfortunately, it's the reality for a lot of patients with rectal cancer who've had rectal surgery. Anne Asnong tries to help these people so that they no longer have to spend their life 'chained' to the toilet seat. 🚽